2,3,4,5-Tetramethoxyphenethylamine

TeMPEA
Clinical data
Other namesTeMPEA; TeMPEA-1; 2,3,4,5-TeMPEA; 2-Methoxymescaline; Methoxymescaline; 2-Methoxy-TMPEA; 3-Methoxy-2C-O; 3-Methoxy-TMPEA-2
ATC code
  • None
Identifiers
  • 2-(2,3,4,5-tetramethoxyphenyl)ethanamine
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC12H19NO4
Molar mass241.287 g·mol−1
3D model (JSmol)
  • COC1=C(C(=C(C(=C1)CCN)OC)OC)OC
  • InChI=1S/C12H19NO4/c1-14-9-7-8(5-6-13)10(15-2)12(17-4)11(9)16-3/h7H,5-6,13H2,1-4H3
  • Key:GJKJPCJLMHZZFK-UHFFFAOYSA-N

2,3,4,5-Tetramethoxyphenethylamine (TeMPEA or 2,3,4,5-TeMPEA), also known as 2-methoxymescaline, is a drug of the phenethylamine family related to mescaline (3,4,5-trimethoxyphenethylamine) and the 2C drugs (4-substituted 2,5-dimethoxyphenethylamines). It was reported to be twice as potent as mescaline in producing behavioral changes in animals. However, it does not seem to have been tested in humans. The drug was not described in Alexander Shulgin's PiHKAL, though it was included in The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. It is a controlled substance in Canada under phenethylamine blanket-ban language. A derivative is 2,3,4,5-tetramethoxyamphetamine (TeMA), which was included in PiHKAL, and was reported to be inactive in humans at the tested doses.

See also